151 related articles for article (PubMed ID: 37824775)
21. Germline mutational analysis of CDH1 and pathologic features in familial cancer syndrome with diffuse gastric cancer/breast cancer proband in a Chinese family.
Zhu ZG; Yu YY; Zhang Y; Ji J; Zhang J; Liu BY; Chen XH; Lu Y; Jiang HS; Bu L; Hu LD; Kong XY
Eur J Surg Oncol; 2004 Jun; 30(5):531-5. PubMed ID: 15135482
[TBL] [Abstract][Full Text] [Related]
22. Overview on new progress of hereditary diffuse gastric cancer with
Hu MN; Hu SH; Zhang XW; Xiong SM; Deng H
Tumori; 2020 Oct; 106(5):346-355. PubMed ID: 32811340
[TBL] [Abstract][Full Text] [Related]
23. CDH1 Missense Variant c.1679C>G (p.T560R) Completely Disrupts Normal Splicing through Creation of a Novel 5' Splice Site.
Yelskaya Z; Bacares R; Salo-Mullen E; Somar J; Lehrich DA; Fasaye GA; Coit DG; Tang LH; Stadler ZK; Zhang L
PLoS One; 2016; 11(11):e0165654. PubMed ID: 27880784
[TBL] [Abstract][Full Text] [Related]
24. Screening for BRCA1, BRCA2, CHEK2, PALB2, BRIP1, RAD50, and CDH1 mutations in high-risk Finnish BRCA1/2-founder mutation-negative breast and/or ovarian cancer individuals.
Kuusisto KM; Bebel A; Vihinen M; Schleutker J; Sallinen SL
Breast Cancer Res; 2011 Feb; 13(1):R20. PubMed ID: 21356067
[TBL] [Abstract][Full Text] [Related]
25. Identification of c.1531C>T Pathogenic Variant in the
Norero E; Alarcon MA; Hakkaart C; de Mayo T; Mellado C; Garrido M; Aguayo G; Lagos M; Torres J; Calvo A; Guilford P; Corvalan AH
Int J Mol Sci; 2019 Oct; 20(20):. PubMed ID: 31600923
[TBL] [Abstract][Full Text] [Related]
26.
Ben Aissa-Haj J; Kabbage M; Othmen H; Saulnier P; Kettiti HT; Jaballah-Gabteni A; Ferah A; Medhioub M; Khsiba A; Mahmoudi M; Maaloul A; Ben Nasr S; Chelbi E; Abdelhak S; Boubaker MS; Azzouz MM; Rouleau E
Genes (Basel); 2022 Feb; 13(3):. PubMed ID: 35327954
[TBL] [Abstract][Full Text] [Related]
27. Outcomes of Endoscopic Surveillance in Individuals With Genetic Predisposition to Hereditary Diffuse Gastric Cancer.
Jacobs MF; Dust H; Koeppe E; Wong S; Mulholland M; Choi EY; Appelman H; Stoffel EM
Gastroenterology; 2019 Jul; 157(1):87-96. PubMed ID: 30935944
[TBL] [Abstract][Full Text] [Related]
28. Clinical features and cancer risk in families with pathogenic
Xicola RM; Li S; Rodriguez N; Reinecke P; Karam R; Speare V; Black MH; LaDuca H; Llor X
J Med Genet; 2019 Dec; 56(12):838-843. PubMed ID: 31296550
[TBL] [Abstract][Full Text] [Related]
29. Frequency of CDH1 germline variants and contribution of dietary habits in early age onset gastric cancer patients in Brazil.
Guindalini RSC; Cormedi MCV; Maistro S; Pasini FS; Branas PCAA; Dos Santos L; de Lima Pereira GF; de Bock GH; Saccaro DM; Katayama MLH; Faraj SF; Safatle-Ribeiro A; Ribeiro Junior U; Diz MDPE; de Gouvêa ACRC; Chammas R; Folgueira MAAK
Gastric Cancer; 2019 Sep; 22(5):920-931. PubMed ID: 30895400
[TBL] [Abstract][Full Text] [Related]
30. Novel CDH1 germline mutations identified in Chinese gastric cancer patients.
Chen QH; Deng W; Li XW; Liu XF; Wang JM; Wang LF; Xiao N; He Q; Wang YP; Fan YM
World J Gastroenterol; 2013 Feb; 19(6):909-16. PubMed ID: 23431106
[TBL] [Abstract][Full Text] [Related]
31. Rare germline variants in the E-cadherin gene CDH1 are associated with the risk of brain tumors of neuroepithelial and epithelial origin.
Förster A; Brand F; Banan R; Hüneburg R; Weber CAM; Ewert W; Kronenberg J; Previti C; Elyan N; Beyer U; Martens H; Hong B; Bräsen JH; Erbersdobler A; Krauss JK; Stangel M; Samii A; Wolf S; Preller M; Aretz S; Wiese B; Hartmann C; Weber RG
Acta Neuropathol; 2021 Jul; 142(1):191-210. PubMed ID: 33929593
[TBL] [Abstract][Full Text] [Related]
32. E-Cadherin (CDH1) and p53 rather than SMAD4 and Caspase-10 germline mutations contribute to genetic predisposition in Portuguese gastric cancer patients.
Oliveira C; Ferreira P; Nabais S; Campos L; Ferreira A; Cirnes L; Alves CC; Veiga I; Fragoso M; Regateiro F; Dias LM; Moreira H; Suriano G; Machado JC; Lopes C; Castedo S; Carneiro F; Seruca R
Eur J Cancer; 2004 Aug; 40(12):1897-903. PubMed ID: 15288293
[TBL] [Abstract][Full Text] [Related]
33. Germline CDH1 variants in hereditary diffuse gastric cancer syndrome with focus on younger women.
Corso G; Comelli G; Veronesi P; Bianchi B; Petitto S; Polizzi A; Girardi A; Cioffi A; La Vecchia C; Bagnardi V; Magnoni F
J Cancer Res Clin Oncol; 2023 Nov; 149(17):16147-16155. PubMed ID: 37639007
[TBL] [Abstract][Full Text] [Related]
34. CDH1 somatic alterations in Mexican patients with diffuse and mixed sporadic gastric cancer.
Bustos-Carpinteyro AR; Oliveira C; Sousa A; Oliveira P; Pinheiro H; Carvalho J; Magaña-Torres MT; Flores-Miramontes MG; Aguilar-Lemarroy A; Jave-Suárez LF; Peregrina-Sandoval J; Cruz-Ramos JA; Sánchez-López JY
BMC Cancer; 2019 Jan; 19(1):69. PubMed ID: 30642281
[TBL] [Abstract][Full Text] [Related]
35. Predicting the Functional Impact of CDH1 Missense Mutations in Hereditary Diffuse Gastric Cancer.
Melo S; Figueiredo J; Fernandes MS; Gonçalves M; Morais-de-Sá E; Sanches JM; Seruca R
Int J Mol Sci; 2017 Dec; 18(12):. PubMed ID: 29231860
[TBL] [Abstract][Full Text] [Related]
36. Screening E-cadherin germline mutations in Italian patients with familial diffuse gastric cancer: an analysis in the District of Urbino, Region Marche, Central Italy.
Graziano F; Ruzzo AM; Bearzi I; Testa E; Lai V; Magnani M
Tumori; 2003; 89(3):255-8. PubMed ID: 12908778
[TBL] [Abstract][Full Text] [Related]
37. Germline E-cadherin gene (CDH1) mutations predispose to familial gastric cancer and colorectal cancer.
Richards FM; McKee SA; Rajpar MH; Cole TR; Evans DG; Jankowski JA; McKeown C; Sanders DS; Maher ER
Hum Mol Genet; 1999 Apr; 8(4):607-10. PubMed ID: 10072428
[TBL] [Abstract][Full Text] [Related]
38. E-cadherin-deficient cells have synthetic lethal vulnerabilities in plasma membrane organisation, dynamics and function.
Godwin TD; Kelly ST; Brew TP; Bougen-Zhukov NM; Single AB; Chen A; Stylianou CE; Harris LD; Currie SK; Telford BJ; Beetham HG; Evans GB; Black MA; Guilford PJ
Gastric Cancer; 2019 Mar; 22(2):273-286. PubMed ID: 30066183
[TBL] [Abstract][Full Text] [Related]
39. CDH1 germline mutations and hereditary lobular breast cancer.
Corso G; Intra M; Trentin C; Veronesi P; Galimberti V
Fam Cancer; 2016 Apr; 15(2):215-9. PubMed ID: 26759166
[TBL] [Abstract][Full Text] [Related]
40. Optimising clinical care through
Luo X; Maciaszek JL; Thompson BA; Leong HS; Dixon K; Sousa S; Anderson M; Roberts ME; Lee K; Spurdle AB; Mensenkamp AR; Brannan T; Pardo C; Zhang L; Pesaran T; Wei S; Fasaye GA; Kesserwan C; Shirts BH; Davis JL; Oliveira C; Plon SE; Schrader KA; Karam R;
J Med Genet; 2023 Jun; 60(6):568-575. PubMed ID: 36600593
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
